422 related articles for article (PubMed ID: 29635999)
1. Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.
Diószegi Á; Tarr T; Nagy-Vincze M; Nánásy-Vass M; Veisz R; Bidiga L; Dezső B; Balla J; Szodoray P; Szekanecz Z; Soltész P
Lupus; 2018 Aug; 27(9):1552-1558. PubMed ID: 29635999
[TBL] [Abstract][Full Text] [Related]
2. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature.
Sukara G; Baresic M; Sentic M; Brcic L; Anic B
Acta Reumatol Port; 2015; 40(2):169-75. PubMed ID: 25782914
[TBL] [Abstract][Full Text] [Related]
3. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature.
Stanescu C; Andronesi AG; Jurcut C; Gherghiceanu M; Vornicu A; Burcea FA; Andronesi TD; Lupusoru GE; Iliuta L; Sorohan BM; Obrisca B; Ismail G
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577835
[TBL] [Abstract][Full Text] [Related]
5. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.
Rymarz A; Niemczyk S
BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138
[TBL] [Abstract][Full Text] [Related]
6. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
[TBL] [Abstract][Full Text] [Related]
7. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus.
González-García A; López-Rodríguez M; Redondo S; Patier JL; Masso P; Tenorio M; Fajardo GS; Sarhane Y; Lacalzada MM; Manzano L
Lupus; 2020 Aug; 29(9):1126-1129. PubMed ID: 32517572
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid Syndrome and the Kidney.
Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].
Pons I; Espinosa G; Cervera R
Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717
[TBL] [Abstract][Full Text] [Related]
10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
11. Renal manifestations of the antiphospholipid syndrome.
Piette JC; Cacoub P; Wechsler B
Semin Arthritis Rheum; 1994 Jun; 23(6):357-66. PubMed ID: 7939722
[TBL] [Abstract][Full Text] [Related]
12. Identification and treatment of APS renal involvement.
Tektonidou MG
Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
[TBL] [Abstract][Full Text] [Related]
14. Renal involvement in antiphospholipid syndrome.
de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
[TBL] [Abstract][Full Text] [Related]
15. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
[TBL] [Abstract][Full Text] [Related]
16. [Catastrophic antiphospholipid syndrome. Communication of 2 forms of presentation].
Grinberg AR; Heller PG; Correa G; Sarano JF; Molinas FC; Nicastro MA; Alvarez CL
Medicina (B Aires); 1999; 59(6):743-6. PubMed ID: 10752219
[TBL] [Abstract][Full Text] [Related]
17. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis.
Cacoub P; Wechsler B; Piette JC; Beaufils H; Herreman G; Bletry O; Godeau P
Clin Exp Rheumatol; 1993; 11(5):479-85. PubMed ID: 8275582
[TBL] [Abstract][Full Text] [Related]
18. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
20. Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience.
Wang CR; Liu MF
Semin Arthritis Rheum; 2016 Aug; 46(1):102-8. PubMed ID: 26992634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
